Cardiovascular risk estimation: important but may be inaccurate
- 31 May 2006
- Vol. 332 (7555) , 1422.1-1422
- https://doi.org/10.1136/bmj.38849.517257.de
Abstract
References 1.↵ Manuel DG, Kwong K, Tanuseputro P, Lim J, Mustard CA, Anderson GM, et al . Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ 2006; 332: 1419–22. 2.↵ Cholesterol Treatment Trialists' (CCT) Collaborators . Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78. 3.↵ Brindle P, Beswick A, Fahey T, Ebrahim S . The accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006 Apr 18; [Epub ahead of print]. 4.↵ Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al . Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267–72. 5.↵ Brindle PM, McConnachie A, Upton MN, Hart CL, Smith GD, Watt GCM . The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract 2005; 55: 838–45.Keywords
This publication has 5 references indexed in Scilit:
- Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic reviewHeart, 2006
- Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling studyBMJ, 2006
- The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.2005
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyBMJ, 2003